INNOVATION PHARMACEUTICALS INC. (IPIX)
Clinical trial NCT05159388 updates: 1. status: COMPLETED → TERMINATED 2. completion date: 2025-04-08 → 2025-04-01 3. primary completion date: 2025-04-08 → 2025-04-01 4. enrollment: 45 → 46 participants
Clinical trial NCT05159388 updates: 1. status: COMPLETED → TERMINATED 2. completion date: 2025-04-08 → 2025-04-01 3. primary completion date: 2025-04-08 → 2025-04-01 4. enrollment: 45 → 46 participants
📈 **POSITIVE** • Low confidence analysis (52%) • Moderate positive clinical data • Good growth prospects **Sentiment:** Positive (55%) **Content type:** Clinical